Pacira BioSciences' Gains from Investment Securities rose 9930.37% to $16.9 million in Q2 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 13032.61%. This contributed to the annual value of -$4.5 million for FY2024, which is 3016.94% down from last year.
Latest data reveals that Pacira BioSciences reported Gains from Investment Securities of $16.9 million as of Q2 2025, which was up 9930.37% from -$5.9 million recorded in Q1 2025.
In the past 5 years, Pacira BioSciences' Gains from Investment Securities registered a high of $16.9 million during Q2 2025, and its lowest value of -$21.3 million during Q2 2022.
In the last 5 years, Pacira BioSciences' Gains from Investment Securities had a median value of -$319500.0 in 2021 and averaged -$1.3 million.
Its Gains from Investment Securities has fluctuated over the past 5 years, first soared by 118478.06% in 2023, then plummeted by 341725.77% in 2024.
Quarter analysis of 5 years shows Pacira BioSciences' Gains from Investment Securities stood at $404000.0 in 2021, then crashed by 1605.45% to -$6.1 million in 2022, then soared by 106.95% to $423000.0 in 2023, then tumbled by 3417.26% to -$14.0 million in 2024, then soared by 220.35% to $16.9 million in 2025.
Its Gains from Investment Securities was $16.9 million in Q2 2025, compared to -$5.9 million in Q1 2025 and -$14.0 million in Q4 2024.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value